EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access

Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology

Lindsay R Meredith iD, Elizabeth M Burnette iD, Steven J Nieto, Han Du, Suzanna Donato, Erica N Grodin, ReJoyce Green, Molly Magill iD, Wave-Ananda Baskerville, Lara A Ray iD

Alcohol: Clinical and Experimental Research · 2023-09 · 47 (9) · 1629-1645

DOI: 10.1111/acer.15143 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Alcohol: Clinical and Experimental Research, online erschienen am 23.07.2023. Verfasst von Lindsay R Meredith und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychology, University of California, Los Angeles, Los Angeles, California, USA. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAAA NIH HHS, National Institute on Alcohol Abuse and Alcoholism.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alcohol cue exposure is a widely used experimental paradigm for screening pharmacotherapies for alcohol use disorder (AUD). Medication‐related reductions in cue‐reactivity signal early efficacy and inform medications development. Yet, across trials, the design of cue exposure, parameter testing, and outcome reporting is heterogeneous. This systematic review is a quantitative synthesis of trial methodologies and effect size estimation for AUD medication‐related craving and psychophysiological outcomes under the cue exposure paradigm. A PubMed search was conducted on January 3, 2022 based on identified pharmacotherapies for peer‐reviewed articles reported in English. Study‐level characteristics, including sample descriptors, paradigm design, analytic approach, and Cochrane Risk of Bias, along with descriptive statistics for cue‐exposure outcomes, were coded by two independent raters. Study‐level effect sizes were estimated for craving and psychophysiological outcomes separately and sample‐level effect sizes were calculated for each medication. Thirty‐six trials, comprising 1640 participants and testing 19 different medications satisfied eligibility criteria. All studies reported on biological sex (71% male participants on average). The exposure paradigms implemented used in vivo ( n = 26), visual ( n = 8), and audio script ( n = 2) cues. Some trials included means for craving by medication condition in text ( k = 7) or figures ( k = 18). The quantitative synthesis included 63 effect sizes (craving k es = 47; psychophysiological k es = 16) from 28 unique randomized trials testing 15 medications for effects on cue reactivity. For cue‐induced craving, eight medications ( k es range: 1–12) demonstrated small‐to‐medium effects (Cohen's d range: |0.24–0.64|) compared to placebo, with individuals randomized to receive medication reporting lower craving following cue exposure. Recommendations are provided to promote further consilience, so that the utility of cue exposure paradigms can be maximized in the development of effective AUD pharmacotherapies. Future work should explore the predictive utility of medication‐related reductions in cue‐reactivity on clinical outcomes.

Schlagwörter

Stichwörter der Autor:innen

alcohol use disordercue-reactivitymedicationspharmacotherapysystematic review

Autor:innen und Institutionen

  • Department of Psychology, University of California, Los Angeles, Los Angeles, California, USA.
  • Brain Research Institute, University of California, Los Angeles, Los Angeles, California, USA.
  • Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, California, USA.
  • Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA.
  • Center for Alcohol and Addiction Studies, Brown University School of Public Health, Providence, Rhode Island, USA.

ORCID-Profile: Lindsay R Meredith, Elizabeth M Burnette, Molly Magill, Lara A Ray

Förderung

  • NIAAA NIH HHS
  • National Institute on Alcohol Abuse and Alcoholism

Zitieren

APA

Meredith, L. R., Burnette, E. M., Nieto, S. J., Du, H., Donato, S., Grodin, E. N., Green, R., Magill, M., Baskerville, W. A., & Ray, L. A. (2023). Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology. Alcohol: Clinical and Experimental Research, 47(9), 1629-1645. https://doi.org/10.1111/acer.15143

Vancouver

Meredith LR, Burnette EM, Nieto SJ, Du H, Donato S, Grodin EN, et al. Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology. Alcohol: Clinical and Experimental Research. 2023;47(9):1629-1645. doi:10.1111/acer.15143

BibTeX
@article{Meredith2023,
  author = {Meredith, Lindsay R and Burnette, Elizabeth M and Nieto, Steven J and Du, Han and Donato, Suzanna and Grodin, Erica N and Green, ReJoyce and Magill, Molly and Baskerville, Wave-Ananda and Ray, Lara A},
  title = {Testing pharmacotherapies for alcohol use disorder with cue exposure paradigms: A systematic review and quantitative synthesis of human laboratory trial methodology},
  journal = {Alcohol: Clinical and Experimental Research},
  year = {2023},
  volume = {47},
  number = {9},
  pages = {1629--1645},
  doi = {10.1111/acer.15143}
}
Kostenlos starten →